title: Towards ligand docking including explicit interface water molecules.
abstract: Small molecule docking predicts the interaction of a small molecule ligand with a protein at atomic-detail accuracy including position and conformation the ligand but also conformational changes of the protein upon ligand binding. While successful in the majority of cases, docking algorithms including RosettaLigand fail in some cases to predict the correct protein/ligand complex structure. In this study we show that simultaneous docking of explicit interface water molecules greatly improves Rosetta's ability to distinguish correct from incorrect ligand poses. This result holds true for both protein-centric water docking wherein waters are located relative to the protein binding site and ligand-centric water docking wherein waters move with the ligand during docking. Protein-centric docking is used to model 99 HIV-1 protease/protease inhibitor structures. We find protease inhibitor placement improving at a ratio of 9:1 when one critical interface water molecule is included in the docking simulation. Ligand-centric docking is applied to 341 structures from the CSAR benchmark of diverse protein/ligand complexes [1]. Across this diverse dataset we see up to 56% recovery of failed docking studies, when waters are included in the docking simulation.
authors.affiliation: Center for Structural Biology, Vanderbilt University, Nashville, Tennessee, United States of America.
authors.forename: Gordon
authors.initials: G
authors.lastname: Lemmon
authors.forename: Jens
authors.initials: J
authors.lastname: Meiler
mesh_terms: D001665:Binding Sites; D016333:HIV Protease / Q000737:chemistry; D008024:Ligands; D008958:Models, Molecular; D062105:Molecular Docking Simulation; D011480:Protease Inhibitors / Q000737:chemistry; D011485:Protein Binding; D011487:Protein Conformation; D011506:Proteins / Q000737:chemistry*; D014867:Water / Q000737:chemistry*
chemical_list: D008024:Ligands; D011480:Protease Inhibitors; D011506:Proteins; D014867:Water; D016333:HIV Protease; C514803:p16 protease, Human immunodeficiency virus 1